Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.00% | -40.06% | -22.99% | -63.49% | -36.49% |
| Total Depreciation and Amortization | 14.98% | -6.62% | -11.70% | 13.91% | -1.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 231.90% | -693.78% | -947.05% | -87.98% | 222.98% |
| Change in Net Operating Assets | -96.14% | 1,092.19% | -73.41% | 517.87% | -177.45% |
| Cash from Operations | -409.79% | 75.85% | -470.62% | 69.27% | -131.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -208.55% | 135.91% | -569.18% | 3,440.27% | -- |
| Cash from Investing | -208.55% | 135.91% | -569.18% | 3,440.27% | -- |
| Total Debt Issued | 207.46% | 434.15% | -2,004.40% | -94.46% | -- |
| Total Debt Repaid | 21.81% | -547.83% | 68.49% | 0.68% | 41.90% |
| Issuance of Common Stock | -96.91% | -78.92% | 282.19% | 521.93% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.99% | -63.38% | 265.26% | 224.37% | 2,356.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.16% | 1,642.70% | -109.43% | 238.52% | -62.71% |